Literature DB >> 2305758

Towards a developmental view of end-stage renal disease.

P L Kimmel1.   

Abstract

Although much study has been devoted to the psychological adjustment of patients treated for end-stage renal disease (ESRD), relatively little attention has been paid to developmental perspectives of the patient with ESRD. ESRD can be divided into four phases: the onset stage, an initial treatment phase, a maturity phase, and a stage of death and dying. The tasks confronted in each phase are dissimilar. The roles of compliance and the medical staff may change in each phase. In particular, the stresses of the maturity phase may be balanced in a complex, enmeshed, and precarious fashion. A developmental view implies that adaptive mechanisms at one stage may be maladaptive in others, and that relationships and ethical viewpoints may change radically as the response to the disease and its treatment progresses. The developmental phase must be taken into consideration when decisions are made in the care of patients with ESRD.

Entities:  

Mesh:

Year:  1990        PMID: 2305758     DOI: 10.1016/s0272-6386(12)80761-x

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  3 in total

1.  Measuring kidney disease-related loss in samples of predialysis and dialysis patients: validating the kidney disease loss scale.

Authors:  Ramony Chan; Robert Brooks; Martin Gallagher; Jonathan Erlich; Paul Snelling; Josephine Chow; Michael Suranyi
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-24       Impact factor: 8.237

2.  Spirituality, social support, and survival in hemodialysis patients.

Authors:  Joann Spinale; Scott D Cohen; Prashant Khetpal; Rolf A Peterson; Brenna Clougherty; Christina M Puchalski; Samir S Patel; Paul L Kimmel
Journal:  Clin J Am Soc Nephrol       Date:  2008-10-15       Impact factor: 8.237

3.  Native Canadians relocating for renal dialysis. Psychosocial and cultural issues.

Authors:  R Wilson; L Krefting; P Sutcliffe; L Van Bussel
Journal:  Can Fam Physician       Date:  1994-11       Impact factor: 3.275

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.